Anti-inflammatory drugs in experimental atherosclerosis

1989 ◽  
Vol 76 (2-3) ◽  
pp. 155-161 ◽  
Author(s):  
A.N. Makheja ◽  
S. Bloom ◽  
R. Muesing ◽  
T. Simon ◽  
J.M. Bailey
1979 ◽  
Vol 32 (2) ◽  
pp. 195-203 ◽  
Author(s):  
J. Martyn Bailey ◽  
A.N. Makheja ◽  
Jean Butler ◽  
K. Salata

Planta Medica ◽  
2010 ◽  
Vol 76 (12) ◽  
Author(s):  
V Francisco ◽  
A Figueirinha ◽  
B Neves ◽  
C Garcia-Rodriguez ◽  
M Lopes ◽  
...  

1996 ◽  
Vol 16 (01) ◽  
pp. 56-59
Author(s):  
D. J. Tyrrell ◽  
C. P. Page

SummaryEvidence continues to accumulate that the pleiotropic nature of heparin (beyond its anticoagulant potency) includes anti-inflammatory activities at a number of levels. It is clear that drugs exploiting these anti-inflammatory activities of heparin may offer exciting new therapeutic applications to the treatment of a wide range of inflammatory diseases.


Sign in / Sign up

Export Citation Format

Share Document